INSR and neuroblastoma: Given the implication of genes involved in activated tyrosine kinase pathways in neuroblastoma, NF1 (a negative regulator of RAS signaling, targeted by homozygous loss), INSR and ITK (both tyrosine kinases, targeted by amplification) were selected for mutation analysis in a panel of neuroblastoma cell lines.